Patents by Inventor Robert Meissner
Robert Meissner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240128467Abstract: An electrical storage device includes high surface area fibers (e.g., shaped fibers and/or microfibers) coated with carbon (graphite, expanded graphite, activated carbon, carbon black, carbon nanofibers, CNT, or graphite coated CNT), electrolyte, and/or electrode active material (e.g., lead oxide) in electrodes. The electrodes are used to form electrical storage devices such as electrochemical batteries, electrochemical double layer capacitors, and asymmetrical capacitors.Type: ApplicationFiled: September 18, 2023Publication date: April 18, 2024Inventors: Richard M. Sturgeon, Dennis A. Wetzel, Robert G. Gruenstern, William J. Wruck, Ramachadran Subbaraman, James Symanski, Eberhard Meissner
-
Publication number: 20230237588Abstract: A method includes displaying a user interface on a screen of a computing device of a homeowner, and receiving an input of an address for a property of the homeowner. The method also includes receiving global positioning system (GPS) data from the computing device, and verifying the address for the property based on the GPS data. The method also includes calculating probabilities for the property to have a flood event at hypothetical high water heights based on GPS located and mapped floodplain data relating to the property, flood zone map data relating to the property, and historical flood data for a region in which the property is located. The method also includes calculating fixed-value payout amounts based on an estimated elevation of the property, the probabilities for the property to have the flood event at the hypothetical high water heights, and estimated flood water depths in the property.Type: ApplicationFiled: April 4, 2023Publication date: July 27, 2023Inventors: Rawle Oliver King, Oliver Robert Meissner
-
Patent number: 11427561Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production. Formula (I) The compounds are IRAK-4 inhibitors useful for treating an inflammatory disease, an autoimmune disease, cancer, a cardiovascular disease, a disease of the central nervous system, a disease of the skin, an ophthalmic disease and condition, and a bone disease.Type: GrantFiled: January 18, 2017Date of Patent: August 30, 2022Assignee: BIOGEN MA INC.Inventors: Timothy Chan, Kevin M. Guckian, Tracy Jenkins, Jermaine Thomas, Jeffrey Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph P. Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield, Nathan Genung
-
Publication number: 20220044331Abstract: A method includes displaying a user interface on a screen of a computing device of a homeowner, and receiving an input of an address for a property of the homeowner. The method also includes receiving global positioning system (GPS) data from the computing device, and verifying the address for the property based on the GPS data. The method also includes calculating probabilities for the property to have a flood event at hypothetical high water heights based on GPS located and mapped floodplain data relating to the property, flood zone map data relating to the property, and historical flood data for a region in which the property is located. The method also includes calculating fixed-value payout amounts based on an estimated elevation of the property, the probabilities for the property to have the flood event at the hypothetical high water heights, and estimated flood water depths in the property.Type: ApplicationFiled: October 25, 2021Publication date: February 10, 2022Inventors: Rawle Oliver King, Oliver Robert Meissner
-
Publication number: 20210188809Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production. Formula (I) The compounds are IRAK-4 inhibitors useful for treating an inflammatory disease, an autoimmune disease, cancer, a cardiovascular disease, a disease of the central nervous system, a disease of the skin, an ophthalmic disease and condition, and a bone disease.Type: ApplicationFiled: January 18, 2017Publication date: June 24, 2021Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffrey Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph P. Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield, Nathan Genung
-
Patent number: 10983043Abstract: A method for categorizing a fracture surface of a component. A digital image of the fracture surface is generated. The digital image or one or more segments of the digital image is/are analyzed, wherein a category of a fracture pattern is assigned to one or more regions of the digital image or of one or more segments based on detection and statistical evaluation of spatial distribution of the smallest homogeneous image units (pixels) or image elements, and, provided that multiple regions and/or multiple segments of the digital image were analyzed, information about the regions and/or details of the digital image and categories of fracture patterns determined and assigned to them are linked to each other, and a category is assigned to the fracture surface based on this link. The method permits automatic, self-learning-categorization of fracture surfaces, for example for series tests carried out for joining technologies.Type: GrantFiled: July 7, 2017Date of Patent: April 20, 2021Assignee: Airbus Defence and Space GmbHInventors: Hauke Brüning, Robert Meissner, André Homeyer, Thomas Körwien
-
Publication number: 20200098052Abstract: A method includes displaying a user interface on a screen of a computing device of a homeowner, and receiving an input of an address for a property of the homeowner. The method also includes receiving global positioning system (GPS) data from the computing device, and verifying the address for the property based on the GPS data. The method also includes calculating probabilities for the property to have a flood event at hypothetical high water heights based on GPS located and mapped floodplain data relating to the property, flood zone map data relating to the property, and historical flood data for a region in which the property is located. The method also includes calculating fixed-value payout amounts based on an estimated elevation of the property, the probabilities for the property to have the flood event at the hypothetical high water heights, and estimated flood water depths in the property.Type: ApplicationFiled: November 27, 2019Publication date: March 26, 2020Inventors: Rawle Oliver King, Oliver Robert Meissner
-
Patent number: 10577367Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.Type: GrantFiled: February 8, 2019Date of Patent: March 3, 2020Assignee: BIOGEN MA INC.Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
-
Publication number: 20190266673Abstract: The present invention is a web-based mobile application, which would serve as a marketplace for agreed value and linear payout flood and other disaster-loss reimbursement protection system. The web application would integrate information about risk and disaster insurance products, including details relating to pricing, coverage and providers, from multiple providers into a single source on an online platform enabling risk-financing customers to compare and purchase risk-financing products entirely online. The web application would expedite the marketing and sale of flood and other disaster risk financing policies by insurance providers by creating a user-friendly, efficient marketplace for the listing and purchase of flood insurance.Type: ApplicationFiled: December 14, 2014Publication date: August 29, 2019Inventors: Rawle Oliver King, Oliver Robert Meissner
-
Publication number: 20190248787Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.Type: ApplicationFiled: February 8, 2019Publication date: August 15, 2019Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
-
Publication number: 20190242811Abstract: A method for categorizing a fracture surface of a component. A digital image of the fracture surface is generated. The digital image or one or more segments of the digital image is/are analyzed, wherein a category of a fracture pattern is assigned to one or more regions of the digital image or of one or more segments based on detection and statistical evaluation of spatial distribution of the smallest homogeneous image units (pixels) or image elements, and, provided that multiple regions and/or multiple segments of the digital image were analyzed, information about the regions and/or details of the digital image and categories of fracture patterns determined and assigned to them are linked to each other, and a category is assigned to the fracture surface based on this link. The method permits automatic, self-learning-categorization of fracture surfaces, for example for series tests carried out for joining technologies.Type: ApplicationFiled: July 7, 2017Publication date: August 8, 2019Inventors: Hauke Brüning, Robert Meissner, André Homeyer, Thomas Körwien
-
Patent number: 10343373Abstract: A coated composite component includes, in this order, a composite component, a fluorine-containing film and/or a fluorine-containing woven fabric, knitted fabric or crocheted fabric, and a tear-off fabric. A method for producing a coated composite component including, in this order, a composite component, a fluorine-containing film and/or a fluorine-containing woven fabric, knitted fabric or crocheted fabric, and a tear-off fabric.Type: GrantFiled: December 16, 2016Date of Patent: July 9, 2019Assignee: Airbus Defence and Space GmbHInventors: Thomas Koerwien, Michael Hoffmann, Robert Meissner, Helmut Wehlan, Andreas Roessmann, Jens Holtmannspoetter, Sebastian Heckner, Thomas Meer, Matthias Geistbeck
-
Patent number: 10246456Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.Type: GrantFiled: July 17, 2015Date of Patent: April 2, 2019Assignee: BIOGEN MA INC.Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
-
Publication number: 20170204093Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.Type: ApplicationFiled: July 17, 2015Publication date: July 20, 2017Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffery Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield
-
Publication number: 20170175307Abstract: A coated composite component includes, in this order, a composite component, a fluorine-containing film and/or a fluorine-containing woven fabric, knitted fabric or crocheted fabric, and a tear-off fabric. A method for producing a coated composite component including, in this order, a composite component, a fluorine-containing film and/or a fluorine-containing woven fabric, knitted fabric or crocheted fabric, and a tear-off fabric.Type: ApplicationFiled: December 16, 2016Publication date: June 22, 2017Inventors: Thomas Koerwien, Michael Hoffmann, Robert Meissner, Helmut Wehlan, Andreas Roessmann, Jens Holtmannspoetter, Sebastian HECKNER, Thomas MEER, Matthias GEISTBECK
-
Patent number: 9663506Abstract: The present invention provides quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined herein. The compounds of the invention are useful as non-competitive mGluR2 antagonists, or mGluR2 negative allosteric modulators (NAMs), and in methods of treating a patient (preferably a human) for diseases or disorders in which the mGluR2-NAM receptor is involved, including potentially Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders, by administering to the patient a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: February 18, 2016Date of Patent: May 30, 2017Assignee: Merck Sharp & Dohme Corp.Inventors: Christopher James Bungard, Antonella Converso, Pablo De Leon, Barbara Hanney, Timothy John Hartingh, Jesse Josef Manikowski, Peter J. Manley, Robert Meissner, Zhaoyang Meng, James J. Perkins, Michael T. Rudd, Youheng Shu
-
Patent number: 9636337Abstract: The present invention provides quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined herein. The compounds of the invention are useful as non-competitive mGluR2 antagonists, or mGluR2 negative allosteric modulators (NAMs), and in methods of treating a patient (preferably a human) for diseases or disorders in which the mGluR2-NAM receptor is involved, including potentially Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders, by administering to the patient a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof.Type: GrantFiled: February 18, 2016Date of Patent: May 2, 2017Assignee: Merck Sharp & Dohme Corp.Inventors: Christopher James Bungard, Antonella Converso, Pablo De Leon, Barbara Hanney, Timothy John Hartingh, Jesse Josef Manikowski, Peter J. Manley, Robert Meissner, Zhaoyang Meng, James J. Perkins, Michael T. Rudd, Youheng Shu
-
Publication number: 20160171615Abstract: The present invention is a web-based mobile application, which would serve as a marketplace for agreed value and linear payout flood and other disaster-loss reimbursement protection system. The web application would integrate information about risk and disaster insurance products, including details relating to pricing, coverage and providers, from multiple providers into a single source on an online platform enabling risk-financing customers to compare and purchase risk-financing products entirely online. The web application would expedite the marketing and sale of flood and other disaster risk financing policies by insurance providers by creating a user-friendly, efficient marketplace for the listing and purchase of flood insurance.Type: ApplicationFiled: December 14, 2014Publication date: June 16, 2016Inventors: Rawle Oliver King, Oliver Robert Meissner
-
Publication number: 20160158217Abstract: The present invention provides quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined herein. The compounds of the invention are useful as non-competitive mGluR2 antagonists, or mGluR2 negative allosteric modulators (NAMs), and in methods of treating a patient (preferably a human) for diseases or disorders in which the mGluR2-NAM receptor is involved, including potentially Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders, by administering to the patient a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: February 18, 2016Publication date: June 9, 2016Applicant: Merck Sharp & Dohme Corp.Inventors: Christopher James Bungard, Antonella Converso, Pablo De Leon, Barbara Hanney, Timothy John Hartingh, Jesse Josef Manikowski, Peter J. Manley, Robert Meissner, Zhaoyang Meng, James J. Perkins, Michael T. Rudd, Youheng Shu
-
Publication number: 20160159744Abstract: The present invention provides quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined herein. The compounds of the invention are useful as non-competitive mGluR2 antagonists, or mGluR2 negative allosteric modulators (NAMs), and in methods of treating a patient (preferably a human) for diseases or disorders in which the mGluR2-NAM receptor is involved, including potentially Alzheimer's disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders, by administering to the patient a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: February 18, 2016Publication date: June 9, 2016Applicant: Merck Sharp & Dohme Corp.Inventors: Christopher James Bungard, Antonella Converso, Pablo De Leon, Barbara Hanney, Timothy John Hartingh, Jesse Josef Manikowski, Peter J. Manley, Robert Meissner, Zhaoyang Meng, James J. Perkins, Michael T. Rudd, Youheng Shu